Compensatory growth (CG) is a period of accelerated growth that occurs following the alleviation of growth-stunting conditions during which an organism can make up for lost growth opportunity and potentially catch up in size with non-stunted cohorts. Fish show a particularly robust capacity for the response and have been the focus of numerous studies that demonstrate their ability to compensate for periods of fasting once food is made available again. CG is characterized by an elevated growth rate resulting from enhanced feed intake, mitogen production, and feed conversion efficiency. Because little is known about the underlying mechanisms that drive the response, this review describes the sequential endocrine adaptations that lead to CG; namely during the precedent catabolic phase (fasting) that taps endogenous energy reserves, and the following hyperanabolic phase (refeeding) when accelerated growth occurs. In order to elicit a CG response, endogenous energy reserves must first be moderately depleted, which alters endocrine profiles that enhance appetite and growth potential. During this catabolic phase, elevated ghrelin and growth hormone (GH) production increase appetite and protein-sparing lipolysis, while insulin-like growth factors (IGFs) are suppressed, primarily due to hepatic GH resistance. During refeeding, temporal hyperphagia provides an influx of energy and metabolic substrates that are then allocated to somatic growth by resumed IGF signaling. Under the right conditions, refeeding results in hyperanabolism and a steepened growth trajectory relative to constantly fed controls. The response wanes as energy reserves are re-accumulated and homeostasis is restored. We ascribe possible roles for select appetite and growth-regulatory hormones in the context of the prerequisite of these catabolic and hyperanabolic phases of the CG response in teleosts, with emphasis on GH, IGFs, cortisol, somatostatin, neuropeptide Y, ghrelin, and leptin.

Growth in fish and other vertebrates is under endocrine control, particularly through the growth hormone (GH)-insulin-like growth factor (IGF) axis. For this reason, it has been of interest to aquaculture researchers and the industry to establish endocrine biomarkers that can both reflect and predict growth rates in fish subject to various biotic and abiotic manipulations. Ultimately, by understanding the hormones that control growth and utilizing them as biomarkers, we hope to achieve optimal growth conditions in the aquaculture environment with less need for lengthy and costly grow-out trials. While the most appropriate endocrine biomarkers for growth can be both species and situation specific, IGF-I may be the most promising candidate for measuring instantaneous growth in fish. This is based on the direct contributions of IGF-I in regulating cell proliferation and ultimately somatic growth, along with its previously established correlations with the specific growth rate in fish under various conditions that alter growth. However, other endocrine indices, such as GH and IGF-binding proteins (IGFBPs), are also important contributors and may in some instances prove a strong corollary to growth rate. This review discusses the potential utility of GH, IGF-I, and IGFBPs as growth biomarkers for those manipulations most relevant to the aquaculture industry, namely, feeding regimen, diet composition, temperature, photoperiod, and stress.

No abstract

No abstract

No abstract